Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population
NCT ID: NCT00718497
Last Updated: 2013-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2007-08-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The benefit of this study may be of substantial value to many people with severe motor impairment. Additionally, it is hoped that some of the study subjects may benefit by incorporating hands-free computer use into their daily lives.
This study is intended to evaluate the effectiveness of the cyberlink as a tool for daily communication compared to the standard manual letter board.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ML for Neck Disability Using Muscle and Joint
NCT05291377
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
NCT07178210
Motion Analysis of the Myelopathy Hand: New Insight Into the Classical Sign
NCT03304236
Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis
NCT02974465
Pattern Recognition Prosthetic Control
NCT04272489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ALS
Subjects having either definite or probable ALS by El Escorial Criteria.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between ages of 18 to 89 years.
* Scored two or less in the ALS FRS category 1 (Speech)
* Scored two or less in the ALS FRS category 4 (Handwriting)
* Cognitively intact with no other neurological diseases
* No unstable medical problems
* Patients unable to give informed consent either themselves or via a legally authorized personnel.
* Patients diagnosed with neurological problems other than ALS (upon examination by the principal investigator)
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MDA/ALS Center of Hope
OTHER
Drexel University College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Terry Heiman-Patterson, MD
Role: PRINCIPAL_INVESTIGATOR
MDA/ALS Center of Hope
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MDA/ALS Center of Hope
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Internal-17018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.